Cargando…
Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MS
Autores principales: | Mehling, Matthias, Eichin, Dominik, Hafner, Patricia, Hönger, Gideon, Kappos, Ludwig, Hess, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204230/ https://www.ncbi.nlm.nih.gov/pubmed/25340080 http://dx.doi.org/10.1212/NXI.0000000000000028 |
Ejemplares similares
-
Combination of teriflunomide and interferon as follow-up therapy
after fingolimod-associated PML
por: Fischer-Barnicol, Bettina, et al.
Publicado: (2020) -
Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod
por: de Jong, Brigit A., et al.
Publicado: (2018) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017) -
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
por: Mehling, Matthias, et al.
Publicado: (2013) -
HSV-2–related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS
por: Ikumi, Kazuhiro, et al.
Publicado: (2016)